Status:
UNKNOWN
Application of NGS in Ascites Infection
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Conditions:
Ascites Infection
Liver Diseases
Eligibility:
All Genders
18-90 years
Brief Summary
Liver cirrhosis is a common serious chronic disease. There are about 123 million patients with liver cirrhosis worldwide, and about 1 million people die of liver cirrhosis every year. The proportion o...
Detailed Description
This study is observational and approximately 50 subjects will be included according to inclusion and exclusion criteria. Patients who meet the inclusion and exclusion criteria, will be were collected...
Eligibility Criteria
Inclusion
- Willing and able to sign informed consent;
- Age ≥ 18 years old;
- Have full civil capacity;
- The amount of ascites is suitable for puncture;
- Ascites infection confirmed by clinical etiology test or clinically suspected ascites infection (such as elevated leukocyte count, elevated procalcitonin, abdominal inflammation indicated by imaging, etc.)
Exclusion
- Those who cannot cooperate with the test;
- Those whose samples cannot be obtained by puncture;
- The cause of ascites is clear;
- Those who are considered to be not suitable for this study
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 25 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05352152
Start Date
July 1 2022
End Date
April 25 2023
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400000